MS Speaks

Multiple Sclerosis => TREATMENTS => Topic started by: agate on June 19, 2017, 08:51:45 pm

Title: Non-approved (off-label) treatments used for MS disease modification
Post by: agate on June 19, 2017, 08:51:45 pm

Cellcept (mycophonolate mofetil), Cladribine, Cytoxan (cyclophosphamide), Imuran (Azothioprine), Minocycline, Rituxan (rituximab), and statins are drugs that are prescribed off-label for MS.

The National MS Society lists them, with brief descriptions, and this list seems important enough to become a "sticky" thread, always near the top of the page:

"Non-approved treatments used for MS disease modification" (http://www.nationalmssociety.org/Treating-MS/Medications/Meds-used-for-MS-off-label).

Title: (Abst.) Anti-JC virus antibody index changes in rituximab-treated MS patients
Post by: agate on August 16, 2018, 03:29:52 pm

From PubMed (August 16, 2018) this abstract of an article by researchers at Beth Israel Deaconess Medical Center in Boston  has the title "Anti-JC virus antibody index changes in rituximab-treated MS patients":


https://www.ncbi.nlm.nih.gov/pubmed/30109480